News ID: 259850
Published: 0736 GMT October 07, 2019

HIV and TB at risk of ‘epidemic rebound’ as funding gaps increase, MSF warns

HIV and TB at risk of ‘epidemic rebound’ as funding gaps increase, MSF warns

Countries across the globe are at risk of witnessing an HIV and tuberculosis (TB) “epidemic rebound” because of a decline in funding, experts have warned.

In a 56-page report published on Monday, global aid agency Médecins Sans Frontières (MSF) said that a rapid shift in funding models for HIV and TB is putting a decade of progress in jeopardy, reported.

The diseases continue to kill more than two million people every year, with 10 million new TB infections in 2017 and 1.7 million new HIV cases last year. Only five countries have met targets to reduce HIV deaths by 75 percent by 2020.

But investment in essential prevention, diagnostic and treatment services is falling as the financial burden is shifting from international donors to affected countries.

According to MSF, this transition is taking place too quickly — with developing countries struggling to compensate for shortfalls.

In 2018 funding for HIV programs from domestic and international sources fell for the first time in more than a decade, dropping by roughly $1 billion (£800 million) in low and middle income countries.

The gap for TB programs is also growing — according to UN figures, the shortfall has now reached $3.5 billion (£2.8 billion).

The MSF report, titled ‘Burden sharing, or burden shifting?’, is based on nine countries where the organization runs HIV and TB programs: Central African Republic, Democratic Republic of Congo, Eswatini, Guinea, Kenya, Malawi, Mozambique, Myanmar and Zimbabwe.

It calls for an urgent “reality check” and funding boosts to prevent disease resurgence — as well as a new assessment to determine how much more money affected countries can realistically commit to TB and HIV programs in the immediate future.

“This recent downward trajectory in funding comes at a critical juncture for the HIV and TB response,” said Dr. Mit Philips, one of the contributing authors of the report.

“While gains made in countries such as Mozambique are at significant risk of backtracking, there is an even higher risk that countries in regions such as West and Central Africa, which are already lagging behind in the HIV and TB response, may see the situation deteriorate even further,” he said.

Security Key:
Captcha refresh
Page Generated in 0/0713 sec